Pitfalls of HbA1c in the Diagnosis of Diabetes.

The Journal of Clinical Endocrinology and Metabolism
Michael BergmanMartin Buysschaert

Abstract

Many health care providers screen high-risk individuals exclusively with an HbA1c despite its insensitivity for detecting dysglycemia. The 2 cases presented describe the inherent caveats of interpreting HbA1c without performing an oral glucose tolerance test (OGTT). The first case reflects the risk of overdiagnosing type 2 diabetes (T2D) in an older African American male in whom HbA1c levels, although variable, were primarily in the mid-prediabetes range (5.7-6.4% [39-46 mmol/mol]) for many years although the initial OGTT demonstrated borderline impaired fasting glucose with a fasting plasma glucose of 102 mg/dL [5.7 mmol/L]) without evidence for impaired glucose tolerance (2-hour glucose ≥140-199 mg/dl ([7.8-11.1 mmol/L]). Because subsequent HbA1c levels were diagnostic of T2D (6.5%-6.6% [48-49 mmol/mol]), a second OGTT performed was normal. The second case illustrates the risk of underdiagnosing T2D in a male with HIV having normal HbA1c levels over many years who underwent an OGTT when mild prediabetes (HbA1c = 5.7% [39 mmol/mol]) developed that was diagnostic of T2D. To avoid inadvertent mistreatment, it is therefore essential to perform an OGTT, despite its limitations, in high-risk individuals, particularly when glucose o...Continue Reading

References

Mar 21, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·C M BennettS C Dharmage
Mar 27, 2007·Diabetes Care·Muhammad A Abdul-GhaniMichael Stern
May 31, 2007·Diabetes Care·William H HermanUNKNOWN Diabetes Prevention Program Research Group
Jul 25, 2007·Archives of Internal Medicine·Elizabeth SelvinJosef Coresh
Sep 29, 2007·Diabetes Care·Robert M Cohen
Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil
Jun 9, 2009·Diabetes Care·Peter S KimColleen Hadigan
Jul 20, 2010·Diabetes Care·Darin E OlsonLawrence S Phillips
Sep 24, 2010·The Journal of Clinical Endocrinology and Metabolism·Kasia J LipskaSilvio E Inzucchi
Dec 7, 2010·The Journal of Clinical Endocrinology and Metabolism·Robert M CohenWilliam H Herman
Jan 18, 2011·European Journal of Internal Medicine·E BartoliG P Carnevale Schianca
Apr 9, 2011·Primary Care Diabetes·Manisha NairK Srinath Reddy
Dec 4, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·B BhowmikA Hussain
Apr 8, 2014·The Lancet. Diabetes & Endocrinology·Robert M Cohen, William H Herman
Oct 15, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne K MonroeTodd T Brown
May 6, 2015·Journal of Diabetes·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Jul 2, 2015·Current Diabetes Reviews·Rogério Tavares RibeiroJoão Filipe Raposo
Jan 23, 2016·Acta Diabetologica·Ram JagannathanMichael Bergman
May 26, 2017·London Journal of Primary Care·P Avari, S Devendra
Jul 20, 2017·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A S MeijnikmanL F Van Gaal
Dec 6, 2017·Diabetes Research and Clinical Practice·Ronald A BoothChantal Lemieux
Jan 10, 2018·Journal of Endocrinological Investigation·F S MirzaL Chirch
Mar 13, 2018·PloS One·Alastair D DuncanBarry S Peters
Jun 18, 2018·Current Diabetes Reports·Melinda E ChenTamara S Hannon

❮ Previous
Next ❯

Citations

Oct 30, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Ram JagannathanMichael Bergman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.